Why is Mounjaro getting so much attention? Is it safer than Ozempic as a weight loss drug?
Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...
Eli Lilly: Growth With Higher Margins
Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...
News243h
Mounjaro Weight Loss Drug Launched In India: Price, How It Works, Side Effects Explained
Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.
Study shows tirzepatide improves biomarkers in overweight, obese adults with type 1 diabetes
In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...
Gastroenterology Advisor21h
Tirzepatide, Semaglutide Not Cost-Effective at Current Prices
According to a recent study, tirzepatide and semaglutide offer long-term health benefits but are not cost-effective.